Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today announced additional data presentations at the American Society of Gene and Cell Therapy (ASGCT) taking place May 16-19, 2018, in Chicago, Ill. This evening at ASGCT, Voyager presented results for its gene therapy program for Friedreich’s ataxia as well as data related to Voyager’s novel adeno-associated virus (AAV) capsid optimization efforts.

Read the entire article HERE


SHARE
 

Scientific News Archives

Tagged in
Scientific News

Beaker

Privacy Policy      Service Terms      Contact      Charity Navigator